Multiple Therapies, One Virus.
KALIVIR is developing cutting-edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer. We design safe and potent oncolytic product candidates to treat patients across mulltiple tumor types. Learn more about us
NEWS AND EVENTS
June 17, 2021 – KaliVir Immunotherapeutics appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors.